Table 3 Specific activity (U mg−1 ± CI) during sampling months
From: Recombinant laccase rPOXA 1B real-time, accelerated and molecular dynamics stability study
Temperature K | 240.98 ± 5.38 | 277.40 ± 1.32 | 297.53 ± 3.88 | 303.27 ± 1.11 | 309.58 ± 0.23 |
Temperature °C | −32.55 ± 4.12 | 4.32 ± 1.22 | 24.99 ± 0.25 | 30.12 ± 1.11 | 36.43 ± 0.23 |
Time (Month) | Specific Activity U mg− 1 ± CI | ||||
1 | 758.92 ± 8.90 | 857.23 ± 10.09 | 745.57 ± 12.32 | 759.46 ± 16.71 | 236.74 ± 4.07 |
2 | 763.62 ± 7.75 | 872.88 ± 9.77 | 737.70 ± 12.11 | 679.41 ± 11.49 | 116.74 ± 2.71 |
3 | 752.30 ± 9.54 | 863.89 ± 9.64 | 663.10 ± 11.70 | 627.46 ± 10.27 | 76.87 ± 3.09 |
4 | 758.06 ± 9.03 | 860.29 ± 10.13 | 587.68 ± 14.01 | 520.02 ± 10.29 | 54.15 ± 2.86 |
5 | 754.66 ± 9.95 | 878.27 ± 9.78 | 567.65 ± 13.30 | 395.92 ± 9.83 | 37.65 ± 1.99 |
6 | 763.25 ± 6.38 | 884.82 ± 10.15 | 563.05 ± 0.0 |  |  |
8 | 787.08 ± 6.27 | 959.30 ± 10.84 |  |  |  |
10 | 759.43 ± 6.30 | 997.01 ± 13.22 |  |  |  |
12 | 934.81 ± 9.70 | 1045.58 ± 15.31 |  |  |  |